Urology
News
Lower urinary tract symptoms bother obese women more than obese men
Major finding: On the Overactive Bladder Questionnaire, more obese women than obese men had higher scores in symptom severity (P = .036), concern...
News
Single-incision sling may help stress urinary incontinence
Major finding: After receiving a single-incision incontinence sling, 90% of women had significant improvements in clinical and quality of life...
News
Prostate cancer stage has declined more than Gleason score
Major finding: Over 22 years, the number of prostate cancers stage T3 or higher fell by 85%, while the number with a Gleason score of 8 or higher...
Conference Coverage
Prolaris test eyed as predictor of prostate cancer outcomes
Major finding: In conservatively managed prostate cancer patients, the cell cycle progression score in tissue samples was the dominant variable...
News
New test beats PSA in predicting significant prostate Ca
Major finding: The probability of significant prostate cancer was 8.5% for men with a Prostate Health Index (phi) level of 27.0-35.9, 14.4% for...
News
Consequences of not screening for prostate cancer prove dire
Major finding: Men who first presented with a PSA score of 100 ng/mL or greater survived a median of just 18 months.Data source: A study of 71 men...
News
Forecast warns of urologist shortage
Major finding: The forecast model estimates a 29% head count reduction and a 25% decrease in the full-time equivalent (FTE) supply of urologists...
News
FDA advisory panel decides tivozanib falls short for advanced renal cell carcinoma
News
Abiraterone reduced morbidity in mCRPC patients
Major finding: The time of radiographic progression-free survival was doubled in patients given abiraterone and prednisone relative to those given...
News
Survival higher with surveillance of small kidney tumors
Major Finding: After 36 months, patients were 63% less likely to have died if their tumors were managed by surveillance instead of surgery (HR, 0....
News
Shorter androgen blockade okay in localized prostate cancer
Major Finding: At 5 years, overall survival was 92% in the 36-month group and 87% in the 18-month group; disease specific survival was 98% and 96...